secwatch.observer — SEC 8-K summary
======================================

Issuer:     Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
CIK:        0001757499
Form:       8-K
Filed at:   2024-09-10T23:59:59+00:00
Accession:  0001493152-24-035667
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Shuttle Pharmaceuticals borrows $250k from CEO at 12% interest, repayable in 12 months
--------------------------------------------------------------------------------

- Issued $250,000 promissory note to CEO Anatoly Dritschilo on September 4, 2024.
- Interest accrues at 12% per annum simple interest; principal and interest due in 12 equal monthly installments.
- Final payment due September 4, 2025; default rate increases to 20%.
- Loan proceeds provide working capital; CEO is the sole lender.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1757499/000149315224035667/0001493152-24-035667-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1757499/000149315224035667/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-035667

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer